Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis

作者：Feng, Zhen; Ni, Yang; Dong, Wei; Shen, Hongchang; Du, Jiajun^*

来源：Molecular Biology Reports, 2012, 39(1): 57-69.

DOI：10.1007/s11033-011-0710-9

• Lung cancer
• ERCC2
• Asp312Asn
• Lys751Gln
• Polymorphism
• Meta-analysis

The association of the two ERCC polymorphisms, Asp312Asn and Lys751Gln, with lung cancer risk remains controversial and inconclusive. To better evaluate the potential role of the two polymorphisms and interaction with tobacco smoking in lung cancer susceptibility presented in diverse populations, we have conducted a meta-analysis based on 26 studies from 24 publications which included analyses of Asp312Asn (7121 cases, 8962 controls) and Lys751Gln (8396 cases, 10510 controls) polymorphisms. Overall, significantly elevated lung cancer risk was associated with ERCC2 312Asn allele(homozygous model: OR = 1.20[1.05-1.36], P = 0.006; recessive model: OR = 1.20[1.06-1.35], P = 0.004) and 751Gln allele(homozygous model: OR = 1.31[1.17-1.46], P < 0.00001; heterozygous model: OR = 1.11[1.04-1.19], P = 0.003; recessive model: OR = 1.23[1.11-1.37], P < 0.0001; dominant model: OR = 1.15[1.08-1.23], P < 0.0001). In ethnic subgroup analyses, significantly increased risk was associated with ERCC2 312Asn allele for both Caucasians and Asians, and 751Gln allele for both Caucasians and Latino-Americans. When stratified by smoking status, significantly elevated risk of both polymorphisms for never-smokers was detected (dominant model, OR = 1.46[1.09-1.95] and 1.57[1.19-2.08], P = 0.01 and 0.002, respectively). In conclusion, this meta-analysis suggests that the two ERCC2 polymorphisms may contribute to lung cancer susceptibility serving as low-penetrance risk factors. Extremely large-scale evidence would be necessary to confirm the effects on ethnically specific populations and gene-environment interactions.

• 出版日期2012-1
• 单位山东大学